Hospice News June 7, 2024
As private equity investors seek out hospice and other health care transactions, they should retrain their sights on potential benefits for patients in addition to financial metrics.
Driving this is a changing regulatory environment as scrutiny heats up for both hospices and the private equity firms themselves. Tightened regulation in the hospice space has led to longer, more stringent diligence processes when it comes to buying and selling provider companies. This means that potential buyers are looking hard at compliance and quality metrics before completing a deal, along with the seller’s financials.
This could signal the start of a paradigm shift in health care dealmaking, Arindam Kar, shareholder at the law firm Polsinelli said during a recent virtual media roundtable.
...Today's Sponsors
Today's Sponsor